Technologists
PBCO is proud to present the New Ig Dose Calculator released June 30, 2021.
The new calculator, which matches the one embedded in the Blood Product Request Portal (BPRP), includes the following upgrades and enhancements:
The calculator should not replace sound clinical judgment concerning a patient's unique situation, the aim being to arrive at the lowest possible dose while maintaining clinical efficacy.
If you have any questions or require support please contact the PBCO at
| Recommendations | Dated |
|
IVIg Utilization Management Program Recommendations Note: The above recommendations are under revision and do not reflect current practice. Effective April 1, 2025, SCIg will be centrally screened for Neurology and Rheumatology Conditions. Follow links for further information on Immunology recommendations for SID and Neurology recommendations for CNS and PNS. |
Jul 2019 |
| TMS Ig Request Process | Dated |
|
Note: Effective April 1, 2025, panels will begin screening SCIg. |
Feb 2025 |
| Provincial Screening Request Form |
Dated |
|
TMS IVIg Screening Request Form TMS SCIg Screening Request Form - Provincial panel screening of SCIg conditions is planned to commence April 1, 2025 For centralized screening of IVIg for all Adult Rheumatology conditions, and Neurology conditions as per the Neurology program guidelines |
Nov 2024 |
| IVIg Outcome Questionnaires | Dated |
|
Peripheral Nervous System Conditions: IVIg Outcome Questionnaire To be used for Non-Approved Adult Peripheral Nervous System conditions only. |
Nov 2024 |
|
Central Nervous System Conditions: IVIg Outcome Questionnaire To be used for Adult Central Nervous System conditions only. |
Nov 2024 |
|
Rheumatology Conditions: IVIg Outcome Questionnaire To be used for Adult Rheumatology conditions only. |
Sep 2022 |
| SCIg Outcome Questionnaires - Provincial panel screening of SCIg conditions is planned to commence April 1, 2025 | Dated |
|
Peripheral Nervous System Conditions: SCIg Outcome Questionnaire To be used for Non-Approved Adult Peripheral Nervous System conditions only. |
Nov 2024 |
|
Central Nervous System Conditions: SCIg Outcome Questionnaire To be used for Adult Central Nervous System conditions only. |
Nov 2024 |
|
Rheumatology Conditions: SCIg Outcome Questionnaire To be used for Adult Rheumatology conditions only. |
Nov 2024 |
| Order Form Templates |
|
The following order form templates were developed by PBCO and adopted by Health Authorities as appropriate:
PBCO can provide these templates upon request. |
Immune Globulin (Ig) is an expensive and limited resource. It is prepared by several commercial manufacturers who use plasma derived from donors to produce IVIg and SCIg.
The BC Provincial Blood Coordinating Office (PBCO) operates an Ig Utilization Management Program to ensure that enough IVIg and/or SCIg is available for patients likely to benefit from the treatment. The program incorporates the:
BC Ministry of Health Policy on Health Authority Immune Globulin Utilization Management Directives which requires that requests for IVIG use are screened in hospital Transfusion Medicine Services to ensure that IVIG is used in accordance with the BC IVIg Utilization Management Program Recommendations.
Note that both the Directives and the Recommendations listed above are currently under review to include SCIg. All requests for SCIg should be handled in the same manner as IVIg effective April 1, 2025.
Two specialty panels support centralized screening. Additional information regarding the Rheumatology and Neurology Screening Programs are found on the following corresponding pages:
 |
 |
 |
 |
 |
 |